Evogene Ltd. EVGN

Company Overview

Evogene Ltd. is an Israeli computational biology and biotechnology company focused on developing life-science products through the application of artificial intelligence, computational predictive biology, and big data technologies. The company operates across the agriculture and human health sectors, using its proprietary Computational Predictive Biology (CPB) platform to identify and optimize biological components such as microbes, small molecules, and genetic elements. Evogene’s activities span crop protection, seed trait development, ag-biologicals, and medical cannabis-related therapeutics and product development.

The company’s business model centers on creating and commercializing technologies through subsidiaries and strategic collaborations. Its primary revenue drivers have historically included research collaborations, licensing arrangements, milestone payments, and technology commercialization. Evogene was founded in 1999 as a division of Compugen and later became an independent publicly traded company listed on Nasdaq under the ticker EVGN. Over time, the company evolved from a crop genetics-focused enterprise into a broader computational biology platform company serving multiple biotechnology verticals.